Hypertension management 2011: optimal combination therapy.

Area of Science:

• Cardiovascular Medicine
• Pharmacology

Background:

• Hypertension arises from complex genetic and environmental interactions.
• Peripheral vascular resistance is a key hemodynamic factor in most hypertension cases.
• Antihypertensive drugs, including vasodilators and sympathetic blockers, aim to reduce blood pressure.

Purpose of the Study:

• To analyze individual patient responses to antihypertensive monotherapy.
• To discuss the implications of variable drug responses in hypertension management.
• To explore next steps in treatment when monotherapy is insufficient.

Main Methods:

• Meta-analysis of placebo-controlled trials of antihypertensive monotherapy.
• Assessment of placebo-corrected blood pressure changes (systolic and diastolic).
• Consideration of counter-regulatory mechanisms opposing blood pressure reduction.

Main Results:

• Average blood pressure reduction with monotherapy is 9.1 mmHg systolic and 5.5 mmHg diastolic.
• Individual responses vary significantly, from a 20-30 mmHg systolic decrease to no effect or even an increase.
• Counter-regulatory mechanisms can oppose initial blood pressure reductions.

Conclusions:

• Monotherapy in hypertension rarely achieves target blood pressure due to variable individual responses and counter-regulation.
• The choice between uptitration, substitution, or combination therapy is critical when monotherapy fails.
• Further research is needed to optimize hypertension treatment strategies based on individual patient profiles.